3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP

Company: NEKTAR THERAPEUTICS
Filed: May 19, 2014
Period of Report: May 19, 2014
Accession Number: 0001181431-14-020214

View Document ↗ View on SEC.gov ↗